Scientists test new inhalable migraine drug in healthy volunteers
NCT ID NCT07226362
Summary
This early-stage study tested how the body absorbs a migraine medication called DHE when delivered through different methods: as an inhaled powder, through a nasal spray, and through an IV. The trial involved 44 healthy adults who tried all four versions of the medication in a random order. Researchers measured how much medication entered the bloodstream and how long it stayed, while checking for safety and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY AND TOLERABILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance for Multispecialty research (AMR)
Knoxville, Tennessee, 37920, United States
Conditions
Explore the condition pages connected to this study.